Saturday, November 22, 2025
HomeTagsNews

news

Mavacamten Demonstrated Significant Reduction in Need for Septal Reduction Therapy in Symptomatic Obstructive HCM Patients in Phase 3 VALOR Trial

Bristol Myers Squibb announced results from the Phase 3 VALOR-HCM study, which showed the addition of mavacamten, an investigational, first-in-class cardiac myosin inhibitor, significantly...

Volta Inc. Provides Business Update

Volta Inc., an industry leading global EV charging network, powering vehicles and commerce, announced preliminary revenues of approximately $12 million for its fourth quarter...

Rocket Lab Launches 112th Satellite to Orbit

Rocket Lab USA, Inc  a leading launch and space systems company, has successfully deployed two satellites to orbit for real-time geospatial intelligence company BlackSky ...

VeriSilicon Joins the Universal Chiplet Interconnect Express Industry Consortium

VeriSilicon (688521.SH), a leading Silicon Platform as a Service (SiPaaS®) company, announced it has officially joined the Universal Chiplet Interconnect Express (UCIe) industry consortium....

TD SYNNEX Achieves AWS Cloud Management Tools Competency

TD SYNNEX announced it has become one of the first distributors to achieve Amazon Web Services (AWS) Cloud Management Tools Competency. The competency is...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics